Pharma Reviews: Pharmac South 2017 to have separate facility for ISM stalls, Ayush manufacturers of 6 south Indian ...

The fourth edition of the south Indian pharmaceutical products exhibition, Pharmac South 2017, to be held in Chennai from 7th to 8th in July will have ...
Read more: Pharmac South 2017 to have separate facility for ISM stalls, Ayush manufacturers of 6 south Indian ...

Pharma Reviews: $250 million push for indigenous pharma innovations

In a bid to boost India's negligible share in the global pharmaceutical market, the central government established Innovate in India mission with an ...
Read more: $250 million push for indigenous pharma innovations

US FDA News: Federal judge orders New York smoked fish company to stop sales due to food safety violations

A New York smoked fish company has been ordered by a federal court to stop selling its products, which were produced in a facility that was contaminated with Listeria monocytogenes (L. mono), until it can comply with food safety regulations.
Read more: Federal judge orders New York smoked fish company to stop sales due to food safety violations

Pharma Reviews: India launches $250 mn national biopharmaceutical mission

“Indian pharmaceutical industry, through the link between academia and industry, will move from picking low hanging fruit from other contexts and ...
Read more: India launches $250 mn national biopharmaceutical mission

Pharma Reviews: In bad times, a good IPO births a new unicorn

After a long time, Indian pharma is at its lowest ebb, in stocks and ... it's a pharma company that is making the domestic market look promising once ...
Read more: In bad times, a good IPO births a new unicorn

Pharma Reviews: Small pharma stores not ready with GST-compliant billing systems, holding stocks

The neighborhood mom-and-pop pharmacy stores dominate the Indian pharmacy retail market, which is pegged at over a trillion rupees annually and ...
Read more: Small pharma stores not ready with GST-compliant billing systems, holding stocks

Pharma Reviews: GST fear: Drug-makers expect shortage of medicines

NEW DELHI: With just a day to go before the roll out of goods and services tax (GST) in India from July 1, the country's drug industry fears that there ...
Read more: GST fear: Drug-makers expect shortage of medicines

Pharma Reviews: Wellness: Back To The Roots

Large corporate players including pioneers such as Himalaya Drug Company, Dabur India, Hindustan Unilever (HUL), EID Parry, OmniActive, ...
Read more: Wellness: Back To The Roots

Pharma Reviews: 20 companies lost over Rs 2-lakh crore market-cap in first half of 2017

“Indian pharma companies have seen a significant correction / multiple de-rating due to an uncertain regulatory environment and pricing pressure (on ...
Read more: 20 companies lost over Rs 2-lakh crore market-cap in first half of 2017

US FDA News: FDA allows marketing of test to aid in the detection of certain leukemias and lymphomas

The U.S. Food and Drug Administration today allowed marketing of ClearLLab Reagents (T1, T2, B1, B2, M), the first agency authorized test for use with flow cytometry to aid in the detection of several leukemias and lymphomas, including chronic leukemia, acute leukemia, non-Hodgkin lymphoma, myeloma, myelodysplastic syndrome (MDS) and myeloproliferative neoplasms (MPN).
Read more: FDA allows marketing of test to aid in the detection of certain leukemias and lymphomas

Pharma Reviews: Pharma companies still facing GST rollout blues

Pharma companies still facing GST rollout blues NEW DELHI | MUMBAI: With two days for implementation of the goods and services tax in India, the ...
Read more: Pharma companies still facing GST rollout blues

Product Recall Alerts: Teething Tablets Recall News: FDA Warning Letter Cites Raritan Pharmaceuticals for Shoddy ...

Raritan Pharmaceuticals recalled teething tablets and other homeopathic medications last November, over fears that the products might contain toxic ...
Read more: Teething Tablets Recall News: FDA Warning Letter Cites Raritan Pharmaceuticals for Shoddy ...

Pharma Reviews: Pharma companies to vendors: Be GST-ready to avoid delay in payments

According to the people in the know, the Indian pharma majors that have told their manufacturers to be GST compliant or face issues in payments ...
Read more: Pharma companies to vendors: Be GST-ready to avoid delay in payments

US FDA News: FDA unveils plan to eliminate orphan designation backlog

Today, the U.S. Food and Drug Administration unveiled a strategic plan to eliminate the agency’s existing orphan designation request backlog and ensure continued timely response to all new requests for designation with firm deadlines. The agency’s Orphan Drug Modernization Plan comes a week after FDA Commissioner Scott Gottlieb committed to eliminating the backlog within 90 days and responding to all new requests for designation within 90 days of receipt during his testimony before a Senate subcommittee.
Read more: FDA unveils plan to eliminate orphan designation backlog

Pharma Reviews: Shardul Amarchand Mangaldas and co advises in relation to the Rs.

Eris Lifesciences is the youngest Indian pharmaceutical company to list its Equity Shares on the Stock Exchanges. It is engaged in developing, ...
Read more: Shardul Amarchand Mangaldas and co advises in relation to the Rs.

Pharma Reviews: USFDA's off-patent drugs list may not offer much to Indian firms

Industry lobby group Indian Pharmaceutical Alliance (IPA) has been asking the USFDA to expedite the review of limited competition products for the ...
Read more: USFDA's off-patent drugs list may not offer much to Indian firms

Pharma Reviews: Aurobindo, Cipla, Biocon top picks; see FDA plan to be double edged sword: Citi

Indian pharma companies were under pressure in the last one year due regulatory issues. Constant warning letters from United States Food & Drug ...
Read more: Aurobindo, Cipla, Biocon top picks; see FDA plan to be double edged sword: Citi

Pharma Reviews: Six industry-specific seminars and two academic symposia to be conducted as part of 'Pharmac ...

Though the expo is mainly supposed to promote the business potential of the south Indian pharma industry, the seminars are meant to educate the ...
Read more: Six industry-specific seminars and two academic symposia to be conducted as part of 'Pharmac ...

Pharma Reviews: India's oldest pharma company Bengal Chemicals turns profitable after 64 years but faces ...

Bengal Chemicals & Pharmaceuticals (BCPL) is turning out to be a template of hope for many of its public sector undertakings (PSUs) peers. India's ...
Read more: India's oldest pharma company Bengal Chemicals turns profitable after 64 years but faces ...

Pharma Reviews: Pharma cos still facing GST rollout blues

NEW DELHI | MUMBAI: With two days for implementation of the goods and services tax in India, the country's pharmaceutical industry fears that ...
Read more: Pharma cos still facing GST rollout blues

Pharma Reviews: 2014 Bilaspur tubectomy deaths: Absconding pharma firm director held

BILASPUR: Police yesterday arrested a director of a pharmaceutical company who has been on the run since 2014 after a case was registered ...
Read more: 2014 Bilaspur tubectomy deaths: Absconding pharma firm director held

Pharma Reviews: US FDA steps add to pricing woes of pharma firms

US FDA steps add to pricing woes of pharma firms ... US citizens — a move that will enable Indian pharmaceutical companies to launch more products ...
Read more: US FDA steps add to pricing woes of pharma firms

Pharma Reviews: OVERCHARGING CASES IN US

A leading financial daily last week reported that some of the major Indian drug companies and their subsidiaries in the US are facing a series of court ...
Read more: OVERCHARGING CASES IN US

Pharma Reviews: Sun Pharma, NIV join hands to fight zika, chikungunya, dengue diseases

Domestic pharma major Sun Pharmaceutical Industries Ltd and National ... The latest agreement with NIV follows Sun Pharma's MoU with Indian ...
Read more: Sun Pharma, NIV join hands to fight zika, chikungunya, dengue diseases

Pharma Reviews: Sun Pharma & NIV sign agreement to fight Zika, Chikungunya and Dengue

Sun Pharmaceutical Industries and The National Institute of Virology (NIV), Pune, an institution of the Indian Council of Medical Research, Department ...
Read more: Sun Pharma & NIV sign agreement to fight Zika, Chikungunya and Dengue

Pharma Reviews: Takeda Pharma, Biological E in pact for vaccine development

Takeda Pharma, Biological E in pact for vaccine development ... Hyderabad, Jun 26 (PTI) Takeda Pharmaceutical Company and Biological E Ltd ... vaccine in India, China and low and middle-income countries where large, unmet ...
Read more: Takeda Pharma, Biological E in pact for vaccine development

Pharma Reviews: Founder and Chairman of Lupin passes away

It was under the leadership of Dr. Gupta that the company grew from being a domestic Indian pharmaceutical company to a global pharmaceutical ...
Read more: Founder and Chairman of Lupin passes away

Pharma Reviews: Lupin founder Desh Bandhu Gupta passes away

Lupin was the only Indian pharmaceutical company to have made inroads into Japan considered to be one of the toughest pharmaceutical markets in ...
Read more: Lupin founder Desh Bandhu Gupta passes away

Pharma Reviews: Lupin founder and Chairman Dr Desh Bandhu Gupta passes away

Since its inception, Lupin has been a pioneer in the Indian pharmaceutical landscape, and it was under the leadership of Dr Gupta that the company ...
Read more: Lupin founder and Chairman Dr Desh Bandhu Gupta passes away

Pharma Reviews: Capsule manufacturing cos plead for lower GST rate of 12-18 per cent

Echoing the concern of capsule manufacturers, the Indian Pharmaceutical Association (IPA), the oldest premier association of pharmaceutical ...
Read more: Capsule manufacturing cos plead for lower GST rate of 12-18 per cent

Pharma Reviews: Barentz International and Indian pharma firm unite to drive South Asia fortification opportunities

Ingredient firm Barentz International is seeking to increase its nutrition and fortifciation opportunities in India by linking up with Noida-based pharma ...
Read more: Barentz International and Indian pharma firm unite to drive South Asia fortification opportunities

Pharma Reviews: NPPA sets up 'GST Facilitation Cell' to help pharma sector, industry in MP still wants clarity

Even as the Indian pharma sector is gearing up for the transition to the Goods and Services Tax (GST) regime from July 1, the industry players in ...
Read more: NPPA sets up 'GST Facilitation Cell' to help pharma sector, industry in MP still wants clarity

Pharma Reviews: NIPER Ahmedabad ties up with J&J to integrate industry practices in medical devices curriculum

Signing of two MoUs with Indian medical devices manufacturers, ... NIPERs and pharma industry for academia industry linkages in the past few years.
Read more: NIPER Ahmedabad ties up with J&J to integrate industry practices in medical devices curriculum

Pharma Reviews: Lupin growth is testimony to pharma pioneer Deshbandhu Gupta vision for domestic, foreign markets

Despite the several run-ins with the regulator over the years, Indian drug firms have managed to gain more than a foothold in the US generics market.
Read more: Lupin growth is testimony to pharma pioneer Deshbandhu Gupta vision for domestic, foreign markets

Pharma Reviews: Government eyes veggie alternative for gelatin capsule coating

The over Rs 1 lakh crore Indian pharmaceutical industry extensively ... The Bureau of Indian Standards has already framed standards, norms and ...
Read more: Government eyes veggie alternative for gelatin capsule coating

US FDA News: Potassium Phosphate and Succinylcholine Chloride by PharMEDium Services: Recall - Lack of Sterility Assurance

Reasonable probability that the patient may experience adverse events ranging from fever, chills and malaise, to severe adverse events including systemic invasive mycoses or systemic bacterial sepsis.
Read more: Potassium Phosphate and Succinylcholine Chloride by PharMEDium Services: Recall - Lack of Sterility Assurance

Pharma Reviews: NPPA steps in to ease GST pain in pharma

The pharma pricing regulator has notified the revised ceiling prices of 761 ... Indian Drug Manufacturers Association (IDMA) President, Deepanth ...
Read more: NPPA steps in to ease GST pain in pharma

Pharma Reviews: Indian industry welcomes Modi-Trump bilateral ties

The mutual commitment to expedite regulatory issues would also be of a great help to the Indian pharmaceutical industry which has been facing ...
Read more: Indian industry welcomes Modi-Trump bilateral ties

US FDA News: FDA Tackles Drug Competition to Improve Patient Access

Today, the U.S. Food and Drug Administration is taking two new, important steps to increase competition in the market for prescription drugs and facilitate entry of lower-cost alternatives. The agency published a list of off-patent, off-exclusivity branded drugs without approved generics, and also implemented, for the first time, a new policy to expedite the review of generic drug applications where competition is limited.
Read more: FDA Tackles Drug Competition to Improve Patient Access

Pharma Reviews: NIV & Sun Pharma sign MoU to test dengue, chikungunya and zika drugs

As part of the agreement, Sun Pharmaceutical Industries Ltd. will provide ... Dengue and chikungunya are major public health concerns in India like ...
Read more: NIV & Sun Pharma sign MoU to test dengue, chikungunya and zika drugs

Pharma Reviews: Sensex closes below 31000, Nifty holds 9500; banks crack

3:30 pm Market at Close: Benchmark indices trimmed some of its losses .... Indian pharma industry will hold its ground when it comes to US market.
Read more: Sensex closes below 31000, Nifty holds 9500; banks crack

Pharma Reviews: Indian Pharma Billionaire Desh Bandhu Gupta Dies

Today his Lupin is India's second largest generics firm deriving more than half of its $2.5 billion revenues from the U. S. and Japan. Gupta, who ...
Read more: Indian Pharma Billionaire Desh Bandhu Gupta Dies

Pharma Reviews: Desh Bandhu Gupta: The humble professor

By Aveek Datta Forbes India Staff .... “With his passing away, India and the pharmaceutical industry has lost one of its tallest leaders,” Khorakiwala ...
Read more: Desh Bandhu Gupta: The humble professor

Pharma Reviews: Indo-US commitment to improve IT sector is commendable, notes ASSOCHAM

Indo-US commitment to improve IT sector is commendable, notes ... New Delhi [India], June 27 : Lauding the commitment shown by India and the United ... also be of great help to the Indian pharmaceutical industry, which has been ...
Read more: Indo-US commitment to improve IT sector is commendable, notes ASSOCHAM

Pharma Reviews: Desh Bandhu Gupta, founder of multinational pharma company Lupin, passes away

Mumbai, Jun 27 (IBNS): Desh Bandhu Gupta, 79, a key figure in the Indian pharmaceutical industry and the founder of multinational phrma company, ...
Read more: Desh Bandhu Gupta, founder of multinational pharma company Lupin, passes away

Pharma Reviews: Sun Pharma, NIV join hands to fight zika, chikungunya, dengue

NEW DELHI: Domestic pharma major Sun Pharmaceutical Industries Ltd and ... The latest agreement with NIV follows Sun Pharma's MoU with Indian ...
Read more: Sun Pharma, NIV join hands to fight zika, chikungunya, dengue

Pharma Reviews: Sun Pharma, NIV ink pact to fight Zika, Chikungunya and Dengue

Mumbai, Jun 27 (UNI) Sun Pharmaceutical Industries and The National Institute of Virology (NIV), Pune, an institution of the Indian Council of Medical ...
Read more: Sun Pharma, NIV ink pact to fight Zika, Chikungunya and Dengue

Pharma Reviews: US commitment on improving IT market access big positive for India: ASSOCHAM

The mutual commitment to expedite regulatory issues would also be of great help to the Indian pharmaceutical industry which has been facing several ...
Read more: US commitment on improving IT market access big positive for India: ASSOCHAM

Pharma Reviews: Sun Pharma, NIV join hands to fight zika, chikungunya, dengue

Domestic pharma major Sun Pharmaceutical Industries Ltd and the ... NIV Pune is an institution of the Indian Council of Medical Research, under the ...
Read more: Sun Pharma, NIV join hands to fight zika, chikungunya, dengue

Pharma Reviews: Beaten-down pharma stocks hope for boost from new USFDA chief

NEW DELHI: The domestic pharmaceutical sector, which has been facing ... of the new FDA commissioner is not the last hope for Indian pharma.
Read more: Beaten-down pharma stocks hope for boost from new USFDA chief

Pharma Reviews: Will continue to do well in UK & Indian markets: Wockhardt

According to him Indian generic companies have been very competitive in the US markets. Indian pharma industry will hold its ground when it comes ...
Read more: Will continue to do well in UK & Indian markets: Wockhardt

Pharma Reviews: Lupin Founder DB Gupta Passes Away

DBG, as he was fondly known in the industry, who established Lupin in 1968 was one of the founding pillars of India's drugs and pharmaceutical ...
Read more: Lupin Founder DB Gupta Passes Away

Pharma Reviews: Market Live: Nifty struggles below 9550, Midcap underperforms; Bharti extends gains

1:05 pm Buzzing stocks: Aurobindo Pharma shares gained more than 3 ... Indian pharma industry will hold its ground when it comes to US market.
Read more: Market Live: Nifty struggles below 9550, Midcap underperforms; Bharti extends gains

Pharma Reviews: The new USFDA commissioner actually knows his job: Amit Rajan, Director, Celogen Life Sciences

What is the impact of the new USFDA Commissioner on Indian pharma companies? He has been believed to have been talking dovish, do you think ...
Read more: The new USFDA commissioner actually knows his job: Amit Rajan, Director, Celogen Life Sciences

Pharma Reviews: Desh Bandhu Gupta, founder of pharma giant-Lupin passes away

Desh Bandhu Gupta, founder and Chairman of Lupin, India's second-largest pharmaceutical company passed away on 26 June 2017 in Mumbai.
Read more: Desh Bandhu Gupta, founder of pharma giant-Lupin passes away

Pharma Reviews: Everyday Health | Why India isn't ready for generic prescriptions yet

With the number of pharma companies mushrooming to well over 10,000, the number of brands available in India is over 110,000 and the average ...
Read more: Everyday Health | Why India isn't ready for generic prescriptions yet

Pharma Reviews: Sun Pharma & NIV sign agreement to fight Zika, Chikungunya and Dengue

Sun Pharma will provide drug molecules to NIV for testing against Zika, ... Sun Pharma's agreement with NIV follows its MOU with Indian Council of ... Shares of SUN PHARMACEUTICAL INDUSTRIES LTD. was last trading in BSE at ...
Read more: Sun Pharma & NIV sign agreement to fight Zika, Chikungunya and Dengue

Pharma Reviews: Drug prices set to rise with GST

The National Pharmaceutical Pricing Authority (NPPA) is expected to draft a notification ... said Daara Patel, Secretary General, Indian Drugs Manufacturing Association. ... Those pharma companies which overcharge are penalised.
Read more: Drug prices set to rise with GST

Pharma Reviews: When Modi meets Trump, buying defence equipment shouldn't be on the agenda

The same policy is also a threat to India's $36 billion pharmaceutical industry, by way of delayed approvals for Indian drug makers. Before the meet ...
Read more: When Modi meets Trump, buying defence equipment shouldn't be on the agenda

Pharma Reviews: Lupin Founder And Chairman Desh Bandhu Gupta Dies At 79

Gupta, an MSc in chemistry, helped Lupin become a pioneer in the Indian pharmaceutical landscape. Gupta started his career as an associate ...
Read more: Lupin Founder And Chairman Desh Bandhu Gupta Dies At 79

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on the importance of the Drug Quality and Security Act and overseeing the safety of compounded drugs

In late 2012, the United States faced the most serious outbreak associated with contaminated compounded drugs in recent history, involving hundreds of people, in many states, who developed fungal infections related to a compounded product. It was an incident that resulted in dozens of deaths.
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on the importance of the Drug Quality and Security Act and overseeing the safety of compounded drugs

Pharma Reviews: Passionate and humble, Lupin founder Desh Bandhu dies at 79

Mumbai: Desh Bandhu Gupta, a doyen of the Indian pharmaceutical industry and a self-made billionaire, who passed away on Monday, will be ...
Read more: Passionate and humble, Lupin founder Desh Bandhu dies at 79

Pharma Reviews: Lupin founder no more

Gupta, who founded Lupin in 1968, played a major role in growing the company from an Indian pharmaceutical firm into a global giant with a presence ...
Read more: Lupin founder no more

Pharma Reviews: Lupin founder and Chairman Desh Bandhu Gupta passes away

Gupta, an MSc in Chemistry, helped Lupin become a pioneer in the Indian pharmaceutical landscape. The company grew from being a domestic ...
Read more: Lupin founder and Chairman Desh Bandhu Gupta passes away

Pharma Reviews: DB Gupta, who borrowed Rs 5000 from wife to set up Lupin, is dead

When Gupta started his pharma business, the Indian market was dominated by multinational companies. Among doctors, too, there was a perception ...
Read more: DB Gupta, who borrowed Rs 5000 from wife to set up Lupin, is dead

Pharma Reviews: Unichem Labs to focus on expansion of product portfolio

The pharma firm will invest in plant expansion, R&D facilities and ... 14.50 per cent as against Indian Pharma Market's (IPM) growth of 10.30 per cent.".
Read more: Unichem Labs to focus on expansion of product portfolio

Pharma Reviews: Pharma Major Lupin Founder-Chairman Desh Bandhu Gupta Passed Away

Gupta, who achieved an MSc in Chemistry, helped Lupin become a pioneer in the Indian pharmaceutical landscape. The company from being a ...
Read more: Pharma Major Lupin Founder-Chairman Desh Bandhu Gupta Passed Away

Pharma Reviews: PM Modi in US: Why India should push for strong healthcare cooperation between the two countries

While India can leapfrog to a more efficient system by learning from the ... world-class generic drugs produced by Indian pharmaceutical companies.
Read more: PM Modi in US: Why India should push for strong healthcare cooperation between the two countries

Pharma Reviews: Desh Bandhu Gupta — the man who made Lupin a pharma giant passes away

The company grew from being a domestic Indian pharmaceutical firm to a global pharmaceutical major. It is now the 4th largest generics ...
Read more: Desh Bandhu Gupta — the man who made Lupin a pharma giant passes away

Pharma Reviews: Founder and Chairman of Lupin Ltd Desh Bandhu Gupta passes away at 79

A report by Economic Times said that Desh Bandhu Gupta had passed on the mantle of managing the third largest pharmaceutical company of India, ...
Read more: Founder and Chairman of Lupin Ltd Desh Bandhu Gupta passes away at 79

Pharma Reviews: Lupin founder and Chairman Desh Bandhu Gupta passes away at 79

Founded by Gupta in 1968, Lupin rose to become the second-largest Indian generics pharmaceutical company by revenue last year. In fact, it is the ...
Read more: Lupin founder and Chairman Desh Bandhu Gupta passes away at 79

Pharma Reviews: Lupin founder Dr Desh Bandhu Gupta passes away

Dr Desh Bandhu Gupta, founder & chairman of Lupin Limited and one of the doyens of Indian pharmaceutical industry, (Lupin), passed away early this ...
Read more: Lupin founder Dr Desh Bandhu Gupta passes away

Pharma Reviews: Lupin founder & Chairman Dr. Desh Bandhu Gupta passes away

Under the leadership of Dr. Gupta the company grew from being a domestic Indian pharmaceutical company to a global pharmaceutical major.
Read more: Lupin founder & Chairman Dr. Desh Bandhu Gupta passes away

Pharma Reviews: Lupin Founder And Chairman Desh Bandhu Gupta Dies

Since its inception, Lupin has been a pioneer in the Indian pharmaceutical landscape, and it was under the leadership of Dr. Gupta that the company ...
Read more: Lupin Founder And Chairman Desh Bandhu Gupta Dies

Pharma Reviews: Lupin founder Desh Bandhu Gupta passes away at 79

MUMBAI: Desh Bandhu Gupta, the self made billionaire and founder chairman of Lupin Limted died early on Monday morning. He was 79 years old.
Read more: Lupin founder Desh Bandhu Gupta passes away at 79

Pharma Reviews: Lupin founder and chairman Desh Bandhu Gupta, creator of global pharma giant, passes away

Gupta (79), founded Lupin in 1968 and created a global pharmaceutical ... The company grew from being a domestic Indian pharmaceutical firm to a ...
Read more: Lupin founder and chairman Desh Bandhu Gupta, creator of global pharma giant, passes away

Pharma Jobs: Most Urgent Vacancy for Regulatory Affairs-api-navi Mumbai

Company: 2COMS Consulting Private Limited
Qualification: M.E/M.Tech/MS, B.Sc, M.Sc
Experience: 2 to 5
location: Mumbai
Ref: 20873511
Summary: Compilation and review of Drug Master Files for ROW Markets based on regulatory and non regulatory requirements. Preparation and Review of CEPs (COS) and US DMFs. ....
Read more: Most Urgent Vacancy for Regulatory Affairs-api-navi Mumbai

Pharma Jobs: Biotechnology walk in Interview 26 June 2017 to 8 July 2017

Company: ACE Group
Experience: 0 to 5
location: Pune
Ref: 20873654
Summary: Biotecnology ,Bsc Msc , B.Tech Are any degree . Candidate should have knowledge of pharma.Chemical , Food with good knowledge of communication skills, Innovate bent of mind, Analytical and Problem solving skills fresher and exp

Read more: Biotechnology walk in Interview 26 June 2017 to 8 July 2017

Pharma Jobs: Biotechnology walk in Interview 26 June 2017 to 8 July 2017

Company: ACE Group
Experience: 0 to 5
location: Mumbai
Ref: 20873660
Summary: Biotecnology ,Bsc Msc , B.Tech Are any degree . Candidate should have knowledge of pharma.Chemical , Food with good knowledge of communication skills, Innovate bent of mind, Analytical and Problem solving skills fresher and exp

Read more: Biotechnology walk in Interview 26 June 2017 to 8 July 2017

Pharma Reviews: 6th Annual InnoPack Pharma Confex

The Indian pharmaceutical market size is expected to grow to USD 100 billion by 2025. By 2020, India is likely to be among the top-3 pharmaceutical ...
Read more: 6th Annual InnoPack Pharma Confex

Pharma Reviews: Sale season starts on D-Street, soon buy stocks at discount

If the bill is passed, Indian pharma companies will have a reduced pie in their fold and will have muted growth prospects under the new framework.
Read more: Sale season starts on D-Street, soon buy stocks at discount

Pharma Reviews: Pharmac South 2017 to focus on products & new technologies of south Indian cos

The exhibition and seminars will see a confluence of top players of Indian pharma industry and marketing leaders from foreign countries as well as ...
Read more: Pharmac South 2017 to focus on products & new technologies of south Indian cos

US FDA News: Succinylcholine Chloride 20mg/mL 5mL Syringe by Fagron Sterile Services: Recall - Potential Lack Of Sterility Assurance

Reasonable probability that patient may experience adverse events ranging from fever, chills and malaise, to severe adverse events including systemic invasive mycoses or systemic bacterial sepsis.
Read more: Succinylcholine Chloride 20mg/mL 5mL Syringe by Fagron Sterile Services: Recall - Potential Lack Of Sterility Assurance

Pharma Reviews: Don't give in to US pressure on tightening generic drug regulations: MSF tells India

MSF alleged that the US government, backed by the pharmaceutical lobby, is expected to step up pressure on several governments, including India ...
Read more: Don't give in to US pressure on tightening generic drug regulations: MSF tells India

Pharma Reviews: Fading glory: Indian pharma industry in uncharted terrain

For Indian pharma companies, the unbridled optimism at the turn of the ... issues, have spelled the end of the dream run for Indian pharma industry.
Read more: Fading glory: Indian pharma industry in uncharted terrain

Pharma Reviews: Pharma: Searching for the recovery room

This March, India's pharma industry's growth was 9.6%, compared with 19.6% in March 2015, according to a market research firm. Photo: Aniruddha ...
Read more: Pharma: Searching for the recovery room

US FDA News: FDA approves first subcutaneous C1 Esterase Inhibitor to treat rare genetic disease

The U.S. Food and Drug Administration today approved Haegarda, the first C1 Esterase Inhibitor (Human) for subcutaneous (under the skin) administration to prevent Hereditary Angioedema (HAE) attacks in adolescent and adult patients. The subcutaneous route of administration allows for easier at-home self-injection by the patient or caregiver, once proper training is received.
Read more: FDA approves first subcutaneous C1 Esterase Inhibitor to treat rare genetic disease

US FDA News: Potassium Phosphate and Succinylcholine by Advanced Pharma: Recall - Potential Lack of Sterility Assurance

Patient may experience adverse events ranging from fever, chills and malaise, to severe adverse events including systemic invasive mycoses or systemic bacterial sepsis.
Read more: Potassium Phosphate and Succinylcholine by Advanced Pharma: Recall - Potential Lack of Sterility Assurance

Pharma Reviews: Current headwinds to help shape M&A contours for Indian pharma

Pharma, healthcare and biotech -together taken as one industry -is among the top five in M&A deals over the past three years, according to data from ...
Read more: Current headwinds to help shape M&A contours for Indian pharma

Pharma Reviews: Indian pharma needs energy efficient cleaning equipment to keep US FDA warnings at bay ...

Indian pharma manufacturers need to invest in energy efficient and cost effective equipment for cleaning. The existing cleaning equipment is ...
Read more: Indian pharma needs energy efficient cleaning equipment to keep US FDA warnings at bay ...

US FDA News: Venture Catheters by Vascular Solutions: Recall - Excess Material May Split or Separate During Use

Material in the patient's bloodstream can result in serious adverse health consequences such as the development of blood clots, embolism of the excess material to vital organs, or death.
Read more: Venture Catheters by Vascular Solutions: Recall - Excess Material May Split or Separate During Use

Pharma Reviews: Global pharma sales face $60 bn hit due to pricing scrutiny: market study

The report states that patent expiries of drugs worth 194 billion will erode the sales of multinational pharma companies but will benefit Indian drug ...
Read more: Global pharma sales face $60 bn hit due to pricing scrutiny: market study

Pharma Reviews: 100 BSE500 stocks scaled new all-time high in June; may rise more

India may have to rapidly re-invent its pharma model if it wants to regain its pre-eminent position. The ball is entirely in the pharma industry's court.
Read more: 100 BSE500 stocks scaled new all-time high in June; may rise more

Pharma Reviews: Make in India programme for SMEs in pharma sector a mirage: Anjan K Roy

Union government's Make in India programme is just a mirage for the small and medium pharma companies because drug manufacturing is capital ...
Read more: Make in India programme for SMEs in pharma sector a mirage: Anjan K Roy

Pharma Reviews: 'Trump impact on generic pharma won't be long term'

India exports generic drugs worth $12.5 billion annually and the U.S is a big market. President Donald Trump has been critical of the fact that the ...
Read more: 'Trump impact on generic pharma won't be long term'

Pharma Reviews: DoP begins consultations to finalise national pharma policy

The associations invited included the Indian Drug Manufacturers' Association, Indian Pharmaceutical Alliance, Organisation of Pharmaceutical ...
Read more: DoP begins consultations to finalise national pharma policy

Pharma Reviews: Bad for health

Currently, 98 per cent of the Indian pharmaceutical industry uses animal parts-based capsules. But the government has been pitching for “vegetarian ...
Read more: Bad for health

US FDA News: U.S. Marshals seize adulterated food from a Minnesota warehouse

The U.S. Food and Drug Administration announced that on June 15, the U.S. Marshals Service seized food products held at Professional Warehouse and Distribution, Inc., in St. Paul, Minnesota. The food products seized are worth approximately $73,000 and include, among other things, barley flour, spices, pasta, dried beans, tea and cookies.
Read more: U.S. Marshals seize adulterated food from a Minnesota warehouse

Pharma Reviews: These 5 Pharma stocks have outperformed Sun Pharma, Cadila Healthcare in the last 3 months

Indian pharmaceutical majors have been under the cloud for some time now, weighed down by a multitude of issues ranging from regulatory concerns ...
Read more: These 5 Pharma stocks have outperformed Sun Pharma, Cadila Healthcare in the last 3 months

Pharma Reviews: Indian drug firms reeling under US anti-trust row

Indian pharmaceutical companies and their subsidiaries in the United States are facing tremendous pressure as they tackle legalities after being ...
Read more: Indian drug firms reeling under US anti-trust row

Pharma Reviews: Indian Investors Ride Out Big-pharma Slump With Small-cap Drugmakers

Mumbai: Investors in Indian pharmaceutical stock, hit by quality-related sanctions against drugmakers operating abroad and reduced pricing power in ...
Read more: Indian Investors Ride Out Big-pharma Slump With Small-cap Drugmakers

US FDA News: System CS100, CS100i and CS300 Intra-Aortic Balloon Pumps by Datascope: Field Correction - Potential Electrical Test Failure Code

Risk of failure of the device to initiate therapy.
Read more: System CS100, CS100i and CS300 Intra-Aortic Balloon Pumps by Datascope: Field Correction - Potential Electrical Test Failure Code

Pharma Reviews: Indian investors ride out big-pharma slump with small-cap drugmakers

Investors in Indian pharmaceutical stock, hit by quality-related sanctions against drugmakers operating abroad and reduced pricing power in more ...
Read more: Indian investors ride out big-pharma slump with small-cap drugmakers

Pharma Reviews: 'Veg capsule for veg society': Govt wants gelatin out of your medicines

According to pharmabiz.com, an online portal for India's pharmaceuticals industry, the Union Health Ministry is looking to replace gelatin capsules with ...
Read more: 'Veg capsule for veg society': Govt wants gelatin out of your medicines

Pharma Reviews: Indian pharma companies should increase base of sales in next few years: Nirmal Bang

From a billion dollar to a USD 2 billion base would be the next rally for Indian pharma companies and that should be accomplished in the next four-five ...
Read more: Indian pharma companies should increase base of sales in next few years: Nirmal Bang

Pharma Reviews: Veg capsules: JP Nadda sets up panel after Maneka push

Currently, over 98 per cent of the Indian pharmaceutical industry uses animal-based gelatin capsules. Plant-based capsules are marketed by just two ...
Read more: Veg capsules: JP Nadda sets up panel after Maneka push

Pharma Reviews: Making healthcare better

It is going to be a game-changer for many industries, including Indian pharmaceutical industry and healthcare in general. Nearly 17 federal and State ...
Read more: Making healthcare better

Pharma Reviews: Chennai to host fourth edition of Pharmac South on July 7-8; 3000 visitors expected to participate

The fourth edition of the Pharmac South, south India's pharmaceutical products and machinery expo, convention and awards event, will be held in ...
Read more: Chennai to host fourth edition of Pharmac South on July 7-8; 3000 visitors expected to participate

US FDA News: Clindamycin Injection ADD-Vantage Vials by Alvogen: Recall - Lack of Sterility Assurance

There is a reasonable probability that the patient may experience adverse events, ranging from fever, chills and malaise, to severe adverse events including systemic invasive mycoses or systemic bacterial sepsis.
Read more: Clindamycin Injection ADD-Vantage Vials by Alvogen: Recall - Lack of Sterility Assurance

US FDA News: Sodium Bicarbonate Injection 8.4 Percent USP, Neut (Sodium Bicarbonate 4 Percent Additive Solution), Quelicin (Succinylcholine Chloride Injection USP), and Potassium Phosphates Injection by Hospira: Recall - Potential For Lack Of Sterility Assurance

A patient may experience adverse events ranging from fever, chills and malaise, to severe adverse events including systemic invasive mycoses or systemic bacterial sepsis. Posted 06/16/2017
Read more: Sodium Bicarbonate Injection 8.4 Percent USP, Neut (Sodium Bicarbonate 4 Percent Additive Solution), Quelicin (Succinylcholine Chloride Injection USP), and Potassium Phosphates Injection by Hospira: Recall - Potential For Lack Of Sterility Assurance

Pharma Reviews: Valuations off highs but uncertainty remains in pharma sector, says Alok Dalal, CLSA

It will have an impact on existing portfolio but at the same time can benefit certain Indian companies. Also, though Indian pharma companies are ...
Read more: Valuations off highs but uncertainty remains in pharma sector, says Alok Dalal, CLSA

Pharma Reviews: Trump's new drug pricing executive order may disrupt pricing of Indian Pharma Companies

A leading news agency reported that drug pricing executive order may come out soon, which may disrupt the profitability of Indian pharmaceutical ...
Read more: Trump's new drug pricing executive order may disrupt pricing of Indian Pharma Companies

Pharma Reviews: Pharma stocks witness selling pressure

A domestic brokerage reportedly said that this move could further create pricing pressure and hurt Indian pharma companies that are already facing ...
Read more: Pharma stocks witness selling pressure

Pharma Reviews: Pharma stocks on the rise, experts say stay away

Much of the recent recovery has just been a valuation play, but taking a medium-term view, the best of the Indian pharma companies are doing the ...
Read more: Pharma stocks on the rise, experts say stay away

US FDA News: Unexpired Nitroglycerin Injection in 5 Percent Dextrose USP by Advanced Pharma in Houston: Recall - Sub Potency

An extreme and unexpected reduction in dose than expected could lead to a delay in treatment, disruption of clinical care of the patient, and worsening of patient’s conditions. Posted 06/15/2017
Read more: Unexpired Nitroglycerin Injection in 5 Percent Dextrose USP by Advanced Pharma in Houston: Recall - Sub Potency

Pharma Reviews: Why is Indian pharma so blasé about tackling disease within?

Pharmaceutical companies could have been better off, if they had paid closer attention to regulatory compliance for the US generic market. While this ...
Read more: Why is Indian pharma so blasé about tackling disease within?

US FDA News: Paliperidone Extended-Release Tablets 3mg by Teva Pharmaceuticals: Recall - Dissolution Test Failure

Failed dissolution could result in less drug being absorbed. Posted 06/15/2017
Read more: Paliperidone Extended-Release Tablets 3mg by Teva Pharmaceuticals: Recall - Dissolution Test Failure

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on the 2016 National Youth Tobacco Survey results

While the latest numbers from the 2016 National Youth Tobacco Survey are encouraging, it is critical that we work to ensure this downward trend continues over the long term across all tobacco products. Every day in the U.S., more than 2,500 youth under the age of 18 smoke their first cigarette and more than 400 youth become daily cigarette smokers. It is also clear from these most recent numbers that youth are continuing to experiment with, or becoming regular users of, a wide range of other tobacco products.
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on the 2016 National Youth Tobacco Survey results

US FDA News: Frameless Stereotaxic Navigation Systems: FDA Safety Communication - Navigational Accuracy Errors

Accuracy errors may lead to patient deaths, serious or life-threatening injuries, and inaccurate, aborted, or prolonged medical procedures Posted 06/15/2017
Read more: Frameless Stereotaxic Navigation Systems: FDA Safety Communication - Navigational Accuracy Errors

US FDA News: Sonar Products ordered to cease operations, Stratus Pharmaceuticals ordered to cease distributing unapproved drugs

Today, U.S. District Judge Kathleen M. Williams for the Southern District of Florida entered a consent decree of permanent injunction between the United States and Stratus Pharmaceuticals Inc. of Miami, Florida, Sonar Products Inc. of Carlstadt, New Jersey and two of the companies’ officers, Alberto Hoyo and Juan Carlos Billoch.
Read more: Sonar Products ordered to cease operations, Stratus Pharmaceuticals ordered to cease distributing unapproved drugs

US FDA News: Topical Products by Phillips Company: Recall - Due to Concerns of Manufacturing Practices

The possibility of decreased quality and consistency of the product, may have an impact on the safety and efficacy of the product posing a risk to patients.
Read more: Topical Products by Phillips Company: Recall - Due to Concerns of Manufacturing Practices

Pharma Reviews: Indian pharma industry scores poorly on digital savvy reps survey

Indian pharma industry scores poorly on digital savvy reps survey Indegene (www.indegene.com), a global healthcare solutions provider today ...
Read more: Indian pharma industry scores poorly on digital savvy reps survey

Pharma Jobs: Urgent Opening for Optometrists in CANADA

Company: Kanvisa Overseas Consultants Private Limited
Qualification: BDS, BAMS, BHMS, B.Pharm, MBBS, MD/MS, M.Pharm, PGDCA, PhD
Experience: 3 to 9
location: Canada
Ref: 20812389
Summary: Optometrists examine eyes and diagnose ocular diseases and disorders. They prescribe and fit....
Read more: Urgent Opening for Optometrists in CANADA

Pharma Reviews: Trade to enhance pharma value proposition

According to a report by the PWC, the Indian pharmaceutical industry is on the threshold of becoming a major global market by 2020. It has a current ...
Read more: Trade to enhance pharma value proposition

Pharma Reviews: Indian drug regulator tightens quality norms, expects greater compliance

“We are aligning our regulatory standards with that of WHO, which is a good thing,” said Daara Patel, Secretary-General of Indian Drug Manufacturers' ...
Read more: Indian drug regulator tightens quality norms, expects greater compliance

US FDA News: Eliquis (apixaban) 5 mg tablets: Recall One Lot- Bottle labeled as Eliquis 5 mg was found to contain Eliquis 2.5 mg tablets

Patients should not stop taking Eliquis without consulting with their physician
Read more: Eliquis (apixaban) 5 mg tablets: Recall One Lot- Bottle labeled as Eliquis 5 mg was found to contain Eliquis 2.5 mg tablets

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D. – FDA is taking new steps to help assess opioid drugs with abuse-deterrent properties

Last month, I asked my colleagues at the FDA to identify what additional and more forceful steps the FDA can take, on top of the vigorous work the agency is already doing, to address the crisis of opioid addiction. Everyone at the FDA is committed to focusing on all aspects of the epidemic. The new policy steps that we announced included the formation of a steering committee to examine additional regulatory and policy actions that we can take to combat this crisis. This steering committee will place particular emphasis on evaluating efforts we can take to reduce the number of new cases of addiction.
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D. – FDA is taking new steps to help assess opioid drugs with abuse-deterrent properties

Pharma Reviews: Sun Pharmaceutical gets US FDA approval for generic anti-cholesterol tablet

Sun Pharmaceutical Industries Ltd, one of India's top pharmaceutical companies, on Tuesday announced that one of its subsidiaries has received final ...
Read more: Sun Pharmaceutical gets US FDA approval for generic anti-cholesterol tablet

Pharma Reviews: Impact of GST on Pharma industry

This is going to be a game-changer for many industries, including Indian Pharmaceutical industry. Nearly 17 federal and state taxes will be replaced ...
Read more: Impact of GST on Pharma industry

Pharma Reviews: Indian Pharma Market clocks slower growth of over 7.2% in May 2017

Indian Pharmaceutical Market (IPM) has registered a slower growth of 7.2 per cent during the month of May 2017as against 9.7 per cent in the ...
Read more: Indian Pharma Market clocks slower growth of over 7.2% in May 2017

Product Recall Alerts: RECALL ALERT: Birth control pill recalled due to risk of contraceptive failure

According to an FDA statement, Lupin Pharmaceuticals Inc. is recalling a specific lot of its Mibelas 24 Fe tablets. The lot affected has the lot number of ...
Read more: RECALL ALERT: Birth control pill recalled due to risk of contraceptive failure

Product Recall Alerts: RECALL ALERT: Mibelas birth control tablets recalled

BALTIMORE, MD. (WLTX) - Lupin Pharmaceuticals has voluntarily recalled one lot of its oral contraceptive Mibelas 24 F-E tablets after a consumer ...
Read more: RECALL ALERT: Mibelas birth control tablets recalled

Pharma Reviews: Top pharma cos have raised their R&D budget to stay relevant: Sameer Baisiwala, Morgan Stanley

Let us talk about the business model of Indian pharma companies. They have enjoyed high multiples for a prolonged period of time and higher ...
Read more: Top pharma cos have raised their R&D budget to stay relevant: Sameer Baisiwala, Morgan Stanley

Pharma Reviews: Global pharma works with Key Opinion Leaders to spur revenue growth by 18-20%

Global pharma companies are increasingly working with key opinion ... Though KOLs work with the Indian pharma companies, their participation is ...
Read more: Global pharma works with Key Opinion Leaders to spur revenue growth by 18-20%

US FDA News: FDA requests removal of Opana ER for risks related to abuse

Today, the U.S. Food and Drug Administration requested that Endo Pharmaceuticals remove its opioid pain medication, reformulated Opana ER (oxymorphone hydrochloride), from the market. After careful consideration, the agency is seeking removal based on its concern that the benefits of the drug may no longer outweigh its risks. This is the first time the agency has taken steps to remove a currently marketed opioid pain medication from sale due to the public health consequences of abuse.
Read more: FDA requests removal of Opana ER for risks related to abuse

Pharma Reviews: Indian drug market growth slows at 7.3% in May

The Indian pharmaceutical market grew at much slower pace in May due to declining sales of anti-infective medicines and sluggish growth in ...
Read more: Indian drug market growth slows at 7.3% in May

Pharma Reviews: Stockists stare at shortage as pharma industry gears up for GST

For the overall Indian Pharmaceutical Market (IPM) there is a reduction of 1.3 days in inventory. AIOCD represents over 500,000 medicines sellers ...
Read more: Stockists stare at shortage as pharma industry gears up for GST

Pharma Reviews: Sun Pharma founder Dilip Shanghvi's net worth takes a $14 billion nose dive in 2 years

Sun Pharma founder Dilip Shanghvi was once India's richest person and ... Additionally, Indian pharma companies in recent times have come under ...
Read more: Sun Pharma founder Dilip Shanghvi's net worth takes a $14 billion nose dive in 2 years

Pharma Reviews: Top five Indian pharma companies together spent over Rs 8000 crore on R&D spend in FY17

Top five Indian pharma companies together spent over Rs 8000 crore on R&D ... Glenmark Pharma, one of the earliest and among the very few local ...
Read more: Top five Indian pharma companies together spent over Rs 8000 crore on R&D spend in FY17

Pharma Reviews: Dilip Shanghvi's net worth fell $14 billion in two years on pharma woes

Mumbai: Dilip Shanghvi's shrinking fortune has become one of the most visible casualties of the troubles hitting India's generic drug industry.
Read more: Dilip Shanghvi's net worth fell $14 billion in two years on pharma woes

Pharma Reviews: Short-term hit likely for pharma

In this scenario, the pharma industry is concerned about the rise in costs. ... be hit post GST, said Santosh Dalvi, partner (indirect tax) at KPMG India.
Read more: Short-term hit likely for pharma

Pharma Reviews: Bringing FDCs under DPCO will shadow half of India Pharma Industry: Ex-Prez IDMA

New Delhi, June 7 (KNN) The Department of Pharmaceuticals recently proposed to include the fixed-dose combinations (FDCs) drugs under the Drug ...
Read more: Bringing FDCs under DPCO will shadow half of India Pharma Industry: Ex-Prez IDMA

Pharma Reviews: $14 billion loss in 2 years for Indian tycoon shows pharma in real bad shape

India's sprawling generic drug industry has come under increased scrutiny as the US Food and Drug Administration steps up inspections of approved ...
Read more: $14 billion loss in 2 years for Indian tycoon shows pharma in real bad shape

Pharma Reviews: Cadila Healthcare's market cap at Rs54,795 crore, making it No. 2 pharma company

Mumbai: Cadila Healthcare Ltd has become India's second-most valuable pharmaceutical company in terms of market capitalisation, beating drug ...
Read more: Cadila Healthcare's market cap at Rs54,795 crore, making it No. 2 pharma company

Pharma Reviews: Dismal show by 32 leading Indian pharma cos in sales & profits during 2016-17

A Pharmabiz study of financial performances of 32 pharmaceutical companies with net sales of Rs.1000 crores and above during year ended March ...
Read more: Dismal show by 32 leading Indian pharma cos in sales & profits during 2016-17

Pharma Reviews: Pharma Woes Axe $14 Billion From Wealth of Once-Richest Indian

(Bloomberg) -- Dilip Shanghvi's shrinking fortune has become one of the most visible casualties of the troubles hitting India's generic drug industry.
Read more: Pharma Woes Axe $14 Billion From Wealth of Once-Richest Indian

Pharma Reviews: Bulk drug parks: Still waiting for financial backing

To counter India's over-dependence on Chinese APIs, Katoch committee ... Currently, Indian pharmaceutical industry imports around 85 per cent of ...
Read more: Bulk drug parks: Still waiting for financial backing

Pharma Reviews: Pricing Pressures To Weigh On India's Pharma Firms: Morgan Stanley's Sameer Baisiwala

Shares of Indian pharmaeutical companies have seen substantial weakness over the last few months with the Nifty Pharma Index falling nearly 11 ...
Read more: Pricing Pressures To Weigh On India's Pharma Firms: Morgan Stanley's Sameer Baisiwala

Pharma Reviews: Nearly half of pharma industry may come under price control

Fixed-dose combinations (FDCs), drugs that include two or more therapeutic ingredients, comprise nearly 40 per cent of Indian drug market, say ...
Read more: Nearly half of pharma industry may come under price control

Pharma Reviews: Worst Ever Quarter For Indian Pharma

For Indian pharma industry, the last quarter of the 2016-2017 financial year was a disastrous one. Most of the companies, including the top and ...
Read more: Worst Ever Quarter For Indian Pharma

Pharma Jobs: Entomologist

Company: M2K Entertainment Private Limited
Qualification: M.Sc
Experience: 5 to 8
location: Gurgaon
Ref: 20781909
Summary: Entomologist

Read more: Entomologist

Pharma Reviews: Warning! India may face heavy shortage of medicines from mid-June due to GST-caused disruption

Sun Pharma, India's largest drug maker too says upcoming GST implementation to have an impact on sales in the first half.“In the Indian market, there ...
Read more: Warning! India may face heavy shortage of medicines from mid-June due to GST-caused disruption

US FDA News: FDA expands use of Sapien 3 artificial heart valve for high-risk patients

The U.S. Food and Drug Administration today approved an expanded indication for the Sapien 3 Transcatheter Heart Valve (THV) for patients with symptomatic heart disease due to failure of a previously placed bioprosthetic aortic or mitral valve whose risk of death or severe complications from repeat surgery is high or greater.
Read more: FDA expands use of Sapien 3 artificial heart valve for high-risk patients

Pharma Reviews: Post GST domestic pharma companies to face headwinds in 1HFY18

Post GST domestic pharma companies to face headwinds in 1HFY18 ... too good for the Indian pharma companies in the first half of FY18 as well.
Read more: Post GST domestic pharma companies to face headwinds in 1HFY18

Pharma Reviews: Drug regulator meets pharma sector bodies on GST and supply

National Pharmaceutical Pricing Authority (NPPA), the national drug pricing ... These bodies include Indian Pharmaceutical Alliance (IPA), All India ...
Read more: Drug regulator meets pharma sector bodies on GST and supply

Pharma Reviews: NPPA meets pharma sector bodies on GST, drug supply

These bodies include Indian Drug Manufacturers Association (IDMA), Indian Pharmaceutical Alliance (IPA), Organisation of Pharmaceutical Producers ...
Read more: NPPA meets pharma sector bodies on GST, drug supply

Pharma Reviews: Trends in Drug Discovery Outsourcing: A Perspective

Chinese and Indian pharmaceutical markets are one of the fastest growing in the world and are considered to be the preferred locations for drug ...
Read more: Trends in Drug Discovery Outsourcing: A Perspective

Pharma Reviews: Japanese firm Rohto Pharma plans to expand base in India

Japanese firm Rohto Pharmaceutical plans to expand its base in India with ... Established in 1899, Rohto makes and markets pharma products, ...
Read more: Japanese firm Rohto Pharma plans to expand base in India

Pharma Reviews: India's pharma sector troubles may not en for another two years; worth buy shares now?

Pharmaceutical companies have been under stress from quite some time particularly companies with high exposure in the US market.
Read more: India's pharma sector troubles may not en for another two years; worth buy shares now?